Title of Invention

PROCESS FOR THE PREPARATION OF PURE FLUPIRTINE MALEATE

Abstract Process for the preparation of pure flupirtine maleate and it's a modification Process for the preparation of pure flupirtine maleate by hydrogenation of 2- amino-3-nitro-6-(4-fluorobenzylamino) pyridine (ANFP) in the presence of Raney nickel, acylation with ethyl chloroformate and reaction of the resulting flupirtine base with maleic acid, characterized in that the hydrogenation, acylation and precipitation are carried out in water-soluble alcohols.
Full Text

Process for the preparation of pure flupirtine maleate
and its A modification
The present invention relates to a process for the
preparation of pure flupirtine maleate and the pure A
crystal modification of flupirtine maleate.
Flupirtine maleate is 2-amino-3-carbethoxyammo-6- (p- J
fluorobenzylammo)pyridine maleate (I) . This compound
is commercially available under the trade name
Katadolon® and is used in particular as an analgesic.
The preparation of flupirtine maleate is described in
DE 31 33 519.
2-amino-3-nitro-6-(4-fluorobenzylamino)pyridine (ANFP)
is dissolved in 2-methoxyethanol and is hydrogenated
with hydrogen in the presence of Raney nickel at 5 bar
and 60°C to give 2,3-diammo-6- (4-fluorobenzyl-
ammo)pyridine. This is acylated with ethyl
chloroformate and triethylamine under inert gas to give
flupirtine base. The catalyst is filtered off and a
solution of isopropanol and maleic acid is added
directly to the filtrate which contains triethylamine
hydrochloride, crude flupirtine maleate being precipi-
tated with vigorous stirring under an inert-gas
atmosphere.
Since it became known that the solvent 2-methoxyethanol
used for the hydrogenation of ANFP is associated with a
health risk owing to its considerable potential danger
in the urogenital region, this compound is an unaccept-
able solvent for this reaction on the industrial scale.
During the precipitation of flupirtine maleate from the
parent base, the avoidance of troublesome coloured
complexes induced by atmospheric oxygen is of decisive
importance. According to the colour intensity, they may
very greatly impair the further purification up to on-
spem flupirtine maleate.

The exclusion of atmospheric oxygen by an intensive
supply of inert gas and a closed reactor system is
therefore absolutely essential in this reaction step.
In a very time-consuming and inconvenient purification
process, crude flupirtine maleate is converted into
crude flupirtine base by liberation with ammonia or
sodium hydroxide solution. The liberation process gives
ammonium or sodium salts which pollute the waste water
and constitute a troublesome accompanying phenomenon
from the ecological point of view. The crude flupirtine
base is recrystallized from isopropanol and, after
clarification with activated carbon/kieselguhr, is
reacted with a solution of maleic acid in isopropanol
to give pure flupirtine maleate.
The complicated process used to date can be illustrated
by the following reaction scheme:
A: ANFP → hydrogenation → acylation → crude
flupirtine base I
B: crude flupirtine base I → maleic acid →
crude flupirtine maleate
C: crude flupirtine maleate → liberation →
crude flupirtine base II
D: crude flupirtine base II → recrystallization
→ pure flupirtine base
E: pure flupirtine base → maleic acid →
modification → pure flupirtine maleate
where reaction steps C - E are required purification
steps without which pure, uniform and on-spec pure
maleate could not be obtained. They are very labour-
intensive and expensive purification operations,


considerably lengthen the synthesis process and lead to
an on-spec pure flupirtine maleate only by a compli-
cated and inconvenient route which is very expensive in
terms of production technology.
The extremely large reactor volumes which are required
for the crystallization of the flupirtine base and for
the precipitation of the flupirtine maleate and tie up
a considerable amount of production capacity are
considered a further criterion indicating a very high
level of technical complexity in the purification steps
C and E.
By metric ton of flupirtine maleate, 25 t of waste
solution which contain 2-methoxyethanol, isopropanol,
ammonia, ammonium maleate and water must be disposed of
by incineration.
This procedure is very uneconomical and difficult to
handle and furthermore does not meet the requirements
for environmentally acceptable production.
The flupirtine maleate is generally obtained as a
mixture of 2 crystal modifications A and B, these being
present in the mixture in different ratios.
Such mixtures present a major problem with regard to
further pharmaceutical processing In particular, this
has an adverse effect with regard to maintaining
constant pharmaceutical production conditions and hence
with respect to guaranteeing the pharmaceutical quality
of an active ingredient. These different mixtures of
crystal modifications lead to different release rates
during release from the pharmaceutical formulation in
the human body. This deficiency may delay the onset of
action of flupirtine maleate as the active ingredient
and hence falsify the activity balance

It is thus the object to develop a simple, environ-
mentally acceptable process for the preparation of pure
flupirtine maleate from which the pure A modification
can be obtained by crystal modification.
According to the invention, the object is achieved by
carrying out the hydrogenation of 2-amino-3-nitro-6-(4-
fluorobenzylamino)pyridine (ANFP) in the presence of
Raney nickel, acylation of the intermediate 2,3-di-
amino-6-(4-fluorobenzylamino)pyridine (DAFP) with ethyl
chloroformate and the reaction of the resulting flupir-
tine base with maleic acid in water-soluble alcohols,
such as ethanol or isopropanol.
The following process variants are possible:
1st process variant:
A: ANFP → hydrogenation → acylation →
crude flupirtine base
B: crude flupirtine base → maleic acid →
crude flupirtine maleate
C - E: not applicable
F: crude maleate → pure maleate
The dissolved and very oxygen-sensitive crude base
synthesized in situ in process step A was con-
verted by a very rapid suction filtration process
into an aqueous maleic acid solution from which
crude flupirtine maleate having far less colour
than the earlier product is immediately precipi-
tated with stirring. After crystallization in
isopropanol-water, said crude flupirtine maleate
gave an on-spec pure maleate in about 85% yield


This dramatic shortening of the preparation pro-
cess for flupirtme maleate in comparison with the
processes practised to date, with bypassing of the
process steps C-E, makes it possible to obtain the
pure maleate directly from the crude flupirtme
maleate and to eliminate the troublesome colour
problems in the flupirtme preparation at an early
stage.
2nd process variant:
A: ANFP → hydrogenation → acylation →
crude flupirtine base
B: flupirtine base v maleic acid → crude
flupirtine maleate
C - F: not applicable
G: without isolation of the crude maleate →
pure maleate
As compared with process step F, process step G
represents a substantially shorter alternative
process in which the precipitation of crude
flupirtme maleate from the flupirtme base formed
in situ in isopropanol is effected by filtration
with suction into an aqueous maleic acid solution
at 50-60°C and, after crystal modification,
colourless pure flupirtine maleate is obtained in
85-90% yield.
3rd process variant:
A. ANFP → hydrogenation → acylation →
crude flupirtme base (isolated)
B. pure flupirtme base → maleic acid →
pure flupirtine maleate

Here, after acylation is complete, the flupirtxne
base is precipitated preferably in ethanol or
water and is purified by simple recrystallization
The preparation of the pure flupirtme maleate is
then carried out analogously to the process
variants mentioned.
It was completely surprising that both the
hydrogenation of ANFP and the acylation of the DAFP
formed with ethyl chloroformate can be carried out in
water-soluble alcohols, such as ethanol or isopropanol.
Here, precipitation in aqueous maleic acid solution
gives a nickel-free flupirtine maleate which no longer
need be subjected to a complicated, multistage
purification process.
The fact that for the first time a white product free
of coloured complexes was obtained in the precipitation
of crude flupirtme maleate, so that here too no addi-
tional purification operations are required, proved to
be a further advantage.
In the subsequent crystal modification to obtain the
pure A modification of flupirtine maleate, it was
found, totally surprisingly, that mixtures of the two
imodifications A and B of flupirtme maleate can be
converted into a ^single-phase flujDirj^ine maleate con-
sisting only of the A modifition under certain
conditions by stirring.
A high proportion of the A modification in the starting
sample, high solids concentration m the suspension
(1:1 to 1:0.8) and temperatures in the range from -10
to 60°C have proved particularly advantageous
At high solids concentration (1-1) and temperatures
between 20 and 60°C, however, it was also possible to

convert flupirtme maleate present predominantly in the
B modification (90% of B) completely into the A
modification in stirring times of 2 to 5 hours, the
fact that the establishment of the desired crystal
modification A can also be achieved at temperatures of
0 to 30°C having been found as a particularly surpris-
ing advantage.
If these discoveries are applied to the precipitation
process (combination of flupirtine base and maleic acid
in a suitable solvent), the conditions required
according to prior art for achieving a very high
primary proportion of the A modification will first be
maintained but then the complete conversion of B
fractions present into the A modification will be
ensured by an appropriately performed stirring process.
Expediently, the stirring process will follow directly
after the precipitation, that is to say that, beginning
during the cooling, the stirring is also continued
after cooling to room temperature until the conversion
is complete. The solids concentration is kept as high
as possible.
Surprisingly, previously unknown crystallized solvates
of flupirtme maleate were found during the recrystal-
lization and precipitation, both in isopropanol and in
ethanol
The solvates observed in the crystal suspensions are
converted into the A modification during the stirring
process On the other hand, no solvate or hydrate
formation is observed when crystals dried beforehand to
constant weight are dispersed in isopropanol, ethanol
or water. The solvates were observed only during the
primary crystallization (nucleation).
Furthermore, it was found that predried crystals which
are freed from externally adsorbed solvent but still

contaxn solvent bound internally within the crystal can
be converted into the B modification by heating to
temperatures of about 80 - 100°C. Subsequent formation
of the B modification from solvate during the technical
drying is prevented by sufficiently long stirring of
the crystal suspension after the maleate precipitation.
Phase analysis
The crystallized phases of flupirtme maleate,
modifications A and B and isopropanol and ethanol
solvate were determined by X-ray diffraction using a
powder diffractometer. In this method, a transformed
image of the crystal structure or structures present is
obtained, which image is formed by summation of the
diffraction effects at a very large number of crystals.
This method is therefore particularly suitable for
determining the composition of mixtures consisting of
different crystallized phases. Fresh, still solvent-
moist samples can also be investigated by this method.
Furthermore, structural changes associated with phase
transitions can be directly observed.
Method: X-ray diffractometry
Diffraction patterns of modifications A and B
The lower part of Figure 1 shows the diffraction
patterns of modifications A and B, and Table 1 shows
the powder data. Both modifications show characteristic
reflections which do not coincide with the reflection
of the respective other modification. These are in
particular the strong reflections at 6.9, 9.2 and
17.9°2d in the case of the A modification and in
particular the strongest reflection at 5.5°2d in the
case of the B modification The limit of detection for
the B modification is ≤ 1% (Figure 2).




Diffraction patterns of the solvates
The upper part of Figure 1 shows the two solvates of
flupirtme maleate.
The diffraction patterns of the solvates differ from
those of modifications A and B in particular in the
occurrence of additional reflections. Solvate is
detectable alongside the two modifications in
particular from the reflection at 6.4°2d (d=13.7 A).
The B modification is detectable alongside solvate
whereas small proportions of the A modification are not
detected alongside solvate. The relationship between
the diffraction patterns of the solvates and the
diffraction pattern of the A modification indicates
that the intracrystalline solvent incorporation takes
place during the nucleation of the A modification.
Thermal reactions of the crystal phases
Methods:
• Differential scanning calorimetry (DSC)
• Thermal gravimetry (TG)
• Temperature-controlled X-ray diffractometry
Figure 3 shows the DSC curves of the two modifications.
The A modification undergoes two endothermic reactions,
that is to say the transformation point A > B at
164 °C (onset) and the melting point for the B
modification at 184°C (onset) The B modification shows
only one endothermic effect at 184°C, which indicates
melting

Figure 4 shows the thermal lattice transformation
A > B. In agreement with the DSC result, the strong
reflection of the B modification at 5.5°29 appears at
165°C.
Figures 5 and 6 show the different courses of the
crystal reactions on heating solvent-moist and predried
crystals, taking crystals obtained from isopropanol as
an example. In the moist state, desolvation occurs
together with release of the externally bound solvent
with formation of the A modification, which is then
converted into the B modification at 164°C
In the dry state, the dehydration takes place at
substantially higher temperature with formation of the
B modification.
Figure 7 shows the thermal lattice transformations in
the case of crystals obtained from isopropanol.
Initially, solvate (6.4°2d) is present alongside the A
modification. At 95°C, the characteristic solvate
reflection disappears and the characteristic reflection
of the B modification at 5.5°29 appears. On further
heating, the characteristic reflections of the A modi-
fication at 6.9 and 9.2°29 also disappear while the
intensity of the B reflection increases greatly.
The process according to the invention for the
preparation of pure flupirtine maleate and of the pure
A modification of flupirtine maleate has the following
decisive advantages:
• In process step A, the unacceptable solvent
2-methoxyethanol is replaced by water-soluble
alcohols, such as isopropanol or ethanol
• In the same process step, the reaction time of the N-
acylation can be reduced from two hours to half an

hour, resulting in a reduction m the range of by-
products and in the concentration of troublesome
coloured complexes.
• The complicated purification steps C - E of the
flupirtine process used to date are dispensed with.
The crude maleate can be converted into pure
flupirtine maleate by a problem-free purification
process or the preparation of the pure flupirtine
maleate is effected directly from the flupirtine base
formed in situ.
• The temperature for the establishment of the pure
crystal modification was reduced from a range of 60
to 65°C to a range of -10 to 60°C.
• It was possible for the first time to prepare the
pure A modification of flupirtine maleate
The process according to the invention is to be
illustrated in more detail with reference to examples:
1st Example
Preparation of pure flupirtine maleate
75 g (0.286 mol) of ANFP are hydrogenated in a
suspension of 12.5 g of Raney nickel in 400 ml of
isopropanol at 65°C and a hydrogen pressure of 5 bar.
After hydrogenation is complete, 26.4 ml of ethyl
chloroformate and then 50.6 ml of triethylamine are
added to the solution. After the addition of a further
6.3 ml of ethyl chloroformate, the reaction solution is
stirred for a further hour at 60°C. The hot solution is
then sucked, with stirring, into a solution of 53.3 g
of maleic acid in 1 5 1 of H2O, which solution has been
heated to 50 - 60°C, and the catalyst is rinsed with a
little isopropanol.

The flupirtxne maleate is precipitated in colourless
form and the crystal suspension is cooled to 20°C with
further stirring and is left at this temperature for 20
minutes. The flupirtine maleate is filtered off with
suction, rinsed with about 500 ml of water and dried in
vacuo at 35°C.
Yield: 107 55 g (89.6% of theory, based on ANFP used).
2nd Example
Preparation of pure flupirtine maleate
18.5 g (0.07 mol) of ANFP are hydrogenated analogously
to Example 1 in a suspension of 2.0 g of Raney nickel
in 140 ml of ethanol at 60 - 70°C and a hydrogen
pressure of 5 bar. After hydrogenation is complete, the
further reaction is carried out at 40 - 50°C with 9.3 g
of ethyl chloroformate (0.86 mol) and 9.2 g of
triethylamme (0.91 mol). The reaction solution separ-
ated from the catalyst is introduced into 540 ml of
water with stirring. After stirring has been carried
out for 2 hours at room temperature, the precipitated
base is filtered off with suction, washed with water
and isopropanol and crystallized in 3.7 times the
amount of isopropanol.
Yield: 18.4 g (86.0% of theory).
The precipitation and modification of pure flupirtine
maleate is carried out according to Examples 7 and 8.
3rd Example
Preparation of the pure A modification of flupirtine
maleate
Dried flupirtine maleate which was crystallized from
isopropanol and contained 10% of the A modification in

addition to 90% of the B modification (Figure 8, bottom
curve) was dispersed in isopropanol in a ratio of
1:0.8. After stirring had been carried out for 200
minutes at 20°C, the characteristic strong B reflection
at 5.5°29 had disappeared and only the characteristic
reflections of the A modification at 6.9 and 9.2°29
were observed (Figure 8. middle curve).
4th Example
Dried flupirtme maleate which was crystallized from
isopropanol and contained 10% of the A modification in
addition to 90% of the B modification was dispersed in
isopropanol in a ratio of 1:0.8 and stirred at 35°C.
After stirring had been carried out for only 70
minutes, the characteristic strong B reflection at
5.5°29 had disappeared and only the characteristic
reflections of the A modification at 6.9 and 9.2° 29
were observed.
5th Example
Slightly less than the maximum soluble amount of
flupirtine maleate was completely dissolved in isoprop-
anol at 60°C, slowly cooled to 20°C and then stirred at
20°C. Before the beginning of stirring, solvate was
observed in addition to the A modification (Figure 9.
bottom curve). After 12 0 minutes, only the A modifica-
tion was detectable (Figure 9. middle curve) No re-
formation of solvate was observed even after the
suspension was allowed to stand for 3 days (Figure 9.
top curve).
6th Example
Slightly less than the maximum soluble amount of
flupirtme maleate was completely dissolved at 60°C in
isopropanol which contained 5% of water, cooled to 20°C
and then stirred at 20°C Before the beginning of

stirring, solvate was present in addition to the A
modification. After stirring had been carried out for
130 minutes, only the A modification was detectable.
7th Example
Stoichiometric amounts of flupirtme base and of maleic
acid were dissolved in isopropanol at 50°C. The
precipitation of the flupirtine maleate was carried out
by dropwise addition of the maleic acid solution to the
solution of the base at 40°C. The freshly precipitated
crystals contained solvate in addition to the B
modification (Figure 10. lower curve) After stirring
had been carried out for only 40 minutes at 40°C, both
the solvate and the B modification had been completely
converted into the A modification (Figure 10, upper
curve).
8th Example
Stoichiometric amounts of flupirtine base and of maleic
acid were dissolved m ethanol at 40°C. The precipita-
tion of the flupirtine maleate was carried out by
dropwise addition of the maleic acid solution to the
solution of the base at 40°C. In the freshly prepared
crystals, only solvate was detectable (Figure 11. lower
curve). After stirring had been carried out for only 15
minutes at 40°C, the solvate had been completely
converted into the A modification (Figure 11. upper
curve).

We Claim:
1. Process for the preparation of pure flupirtine maleate by
hydrogenation of 2-amino-3-nitro-6-(4-fiuorobenzylamino)
pyridine (ANFP) in the presence of Raney nickel, acylation with
ethyl chloroformate and reaction of the resulting flupirtine base
with maleic acid, characterized in that the hydrogenation, acylation
and precipitation are carried out in water-soluble alcohols.
2. Process as claimed in claim 1, wherein the alcohols used are
preferably ethanol or isopropanol.
3. Process as claimed in claim 1, wherein either

a) the crude flupirtine maleate is isolated and is converted into
[sic] the pure maleate or
b) the maleate is precipitated by reacting the flupirtine base
formed in situ with maleic acid and is converted into the pure
flupirtine maleate without isolation or
c) the crude flupirtine base is precipitated and recrystallized and
then converted into pure flupirtine maleate by reaction with
maleic acid
4. Process as claimed in any of claims 1 to 3, wherein the reaction is
carried out at a temperature between -10 and 60°C.

5. Process for the preparation of the pure 'A' modification of flupirtine
maleate, characterized in that the flupirtine maleate obtained as
claimed in any of claims 1 to 3 is stirred in optionally water-
containing isopropanol or ethanol.
6. Process as claimed in claim 5, wherein the stirring process is
preferably carried out in the reaction mixture as claimed in claim
3 c, containing flupirtine maleate which has crystallized out.
7. Process as claimed in claim 5, wherein the stirring process is
carried out at temperature between -10 and 60°C.


ABSTRACT

Title: Process for the preparation of pure flupirtine maleate and it's a
modification
Process for the preparation of pure flupirtine maleate by hydrogenation of 2-
amino-3-nitro-6-(4-fluorobenzylamino) pyridine (ANFP) in the presence of
Raney nickel, acylation with ethyl chloroformate and reaction of the
resulting flupirtine base with maleic acid, characterized in that the
hydrogenation, acylation and precipitation are carried out in water-soluble
alcohols.

Documents:

676-cal-1998-abstract.pdf

676-cal-1998-assignment.pdf

676-CAL-1998-CANCELLED COPY.pdf

676-cal-1998-claims.pdf

676-cal-1998-correspondence.pdf

676-CAL-1998-CORRESPONDENCE1.1.pdf

676-cal-1998-description (complete).pdf

676-cal-1998-drawings.pdf

676-cal-1998-examination report.pdf

676-cal-1998-form 1.pdf

676-cal-1998-form 18.pdf

676-cal-1998-form 2.pdf

676-cal-1998-form 3.pdf

676-cal-1998-form 5.pdf

676-CAL-1998-FORM 6.pdf

676-CAL-1998-GPA.pdf

676-CAL-1998-GRANTED-ABSTRACT.pdf

676-CAL-1998-GRANTED-CLAIMS.pdf

676-CAL-1998-GRANTED-DESCRIPTION (COMPLETE).pdf

676-CAL-1998-GRANTED-DRAWINGS.pdf

676-CAL-1998-GRANTED-FORM 1.pdf

676-CAL-1998-GRANTED-FORM 2.pdf

676-CAL-1998-GRANTED-FORM 3.pdf

676-CAL-1998-GRANTED-FORM 5.pdf

676-CAL-1998-GRANTED-SPECIFICATION-COMPLETE.pdf

676-cal-1998-pa.pdf

676-CAL-1998-PETITION UNDER RULE 137.pdf

676-cal-1998-priority document.pdf

676-CAL-1998-REPLY TO EXAMINATION REPORT.pdf

676-cal-1998-specification.pdf

676-cal-1998-translated copy of priority document.pdf


Patent Number 255298
Indian Patent Application Number 676/CAL/1998
PG Journal Number 07/2013
Publication Date 15-Feb-2013
Grant Date 11-Feb-2013
Date of Filing 20-Apr-1998
Name of Patentee AWD PHARMA GMBH & CO. KG.
Applicant Address LEIPZIGER STRASSE 7-13, 01097 DRESDEN
Inventors:
# Inventor's Name Inventor's Address
1 DR. ALFRED OLBRICH SAUERBRUCHSTRASSE 13, 33790 HALLE/WESTF
2 PROF. BERNHARD KUTSCHER STRESEMANNSTRASSE 9, 63477 MAINTAL
3 DR. KARL- FRIEDRICH LANDGRAF HEINRICH-GREIF-STRASSE 37, 01217 DRESDEN
4 SIEGFRIED PAULUHN WALDPARKRING 16, 74731 WALLDURN-REINHARDSACHSEN
5 DR. HANS STANGE DRESDNER STRASSE 3, 01587 RIESA
6 DR. PETER EMIG LUDWIG-ERHARD-STRASSE 22, 63486 BRUCHKOBLE
PCT International Classification Number C07D 213/00
PCT International Application Number N/A
PCT International Filing date
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 197 16 984.8 1997-04-23 Germany